|
1
|
do Amaral LA, da Silva Fleming de Almeida T, Oliveira de Souza GH, Baranoski A, Souza Maris R, Bittencourt Junior FF, Murino Rafacho BP, Duenhas Monreal AC, Leite Kassuya CA, Milan Brochado Antoniolli-Silva AC, Freitas dos Santos E, Oliveira RJ. The Use of Natural Fiber-Rich Food Product Is Safe and Reduces Aberrant Crypt Foci in a Pre-Clinical Model. Nutrients 2021; 13:2708. [PMID: 34444868 PMCID: PMC8401268 DOI: 10.3390/nu13082708] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2021] [Revised: 07/05/2021] [Accepted: 07/10/2021] [Indexed: 12/02/2022] Open
Abstract
BACKGROUND Colorectal cancer is a highly prevalent disease, requiring effective strategies for prevention and treatment. The present research aimed to formulate a natural fiber-rich food product (NFRFP) and to evaluate its safety, toxicogenetics, and effects on aberrant crypt foci induced by 1,2-dimethyl-hydrazine in a preclinical model. METHODS A total of 78 male Wistar rats were distributed in six experimental groups: negative control, positive control (1,2-Dimethylhydrazine-40 mg/Kg), and four groups fed with 10% NFRFP: NFRFP, pre-treatment protocol, simultaneous treatment, and post-treatment protocol. RESULTS The NFRFP was shown to be a good source of fibers and did not change biometric, biochemical, hematological, and inflammatory parameters, and did not induce signs of toxicity and genotoxicity/carcinogenicity. NFRFP exhibited a chemopreventive effect, in all protocols, with damage reduction (% DR) of 75% in the comet test. NFRFP reduced the incidence of aberrant crypt outbreaks by 49.36% in the post-treatment protocol. CONCLUSIONS The results suggest the applicability of NFRFP in the human diet due to potential production at an industrial scale and easy technological application in different products, since it could be incorporated in food without altering or causing small changes in final product sensory characteristics.
Collapse
Affiliation(s)
- Luane Aparecida do Amaral
- Center for Studies in Stem Cells, Cell Therapy and Toxicological Genetics–CeTroGen, University Hospital Maria Aparecida Pedrossian, Federal University of Mato Grosso do Sul, Campo Grande 79080-190, Brazil; (L.A.d.A.); (A.B.); (A.C.M.B.A.-S.)
- Postgraduate Program in Health and Development in the Midwest Region, Medical School, Federal University of Mato Grosso do Sul, Campo Grande 79070-900, Brazil;
| | - Taina da Silva Fleming de Almeida
- Postgraduate Program in Biotechnology, Faculty of Pharmaceutical Sciences, Food and Nutrition, Federal University of Mato Grosso do Sul, Campo Grande 79070-900, Brazil; (T.d.S.F.d.A.); (B.P.M.R.)
| | | | - Adrivanio Baranoski
- Center for Studies in Stem Cells, Cell Therapy and Toxicological Genetics–CeTroGen, University Hospital Maria Aparecida Pedrossian, Federal University of Mato Grosso do Sul, Campo Grande 79080-190, Brazil; (L.A.d.A.); (A.B.); (A.C.M.B.A.-S.)
- Postgraduate Program in Health and Development in the Midwest Region, Medical School, Federal University of Mato Grosso do Sul, Campo Grande 79070-900, Brazil;
| | - Rafael Souza Maris
- Clinical Analysis Laboratory, University Center of Grande Dourados, Dourados 79824-900, Brazil; (R.S.M.); (F.F.B.J.)
| | | | - Bruna Paola Murino Rafacho
- Postgraduate Program in Biotechnology, Faculty of Pharmaceutical Sciences, Food and Nutrition, Federal University of Mato Grosso do Sul, Campo Grande 79070-900, Brazil; (T.d.S.F.d.A.); (B.P.M.R.)
- Faculty of Pharmaceutical Sciences, Food and Nutrition, Federal University of Mato Grosso do Sul, Campo Grande 79070-900, Brazil;
- Postgraduate Program in Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Food and Nutrition, Federal University of Mato Grosso do Sul, Campo Grande 79070-900, Brazil
| | | | | | - Andréia Conceição Milan Brochado Antoniolli-Silva
- Center for Studies in Stem Cells, Cell Therapy and Toxicological Genetics–CeTroGen, University Hospital Maria Aparecida Pedrossian, Federal University of Mato Grosso do Sul, Campo Grande 79080-190, Brazil; (L.A.d.A.); (A.B.); (A.C.M.B.A.-S.)
- Postgraduate Program in Health and Development in the Midwest Region, Medical School, Federal University of Mato Grosso do Sul, Campo Grande 79070-900, Brazil;
| | - Elisvânia Freitas dos Santos
- Postgraduate Program in Health and Development in the Midwest Region, Medical School, Federal University of Mato Grosso do Sul, Campo Grande 79070-900, Brazil;
- Postgraduate Program in Biotechnology, Faculty of Pharmaceutical Sciences, Food and Nutrition, Federal University of Mato Grosso do Sul, Campo Grande 79070-900, Brazil; (T.d.S.F.d.A.); (B.P.M.R.)
- Faculty of Pharmaceutical Sciences, Food and Nutrition, Federal University of Mato Grosso do Sul, Campo Grande 79070-900, Brazil;
| | - Rodrigo Juliano Oliveira
- Center for Studies in Stem Cells, Cell Therapy and Toxicological Genetics–CeTroGen, University Hospital Maria Aparecida Pedrossian, Federal University of Mato Grosso do Sul, Campo Grande 79080-190, Brazil; (L.A.d.A.); (A.B.); (A.C.M.B.A.-S.)
- Postgraduate Program in Health and Development in the Midwest Region, Medical School, Federal University of Mato Grosso do Sul, Campo Grande 79070-900, Brazil;
- Postgraduate Program in Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Food and Nutrition, Federal University of Mato Grosso do Sul, Campo Grande 79070-900, Brazil
| |
Collapse
|